AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-κB mediated uPAR activation.
about
AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-κB mediated uPAR activation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
AduPARE1A and gemcitabine comb ...... F-κB mediated uPAR activation.
@en
type
label
AduPARE1A and gemcitabine comb ...... F-κB mediated uPAR activation.
@en
prefLabel
AduPARE1A and gemcitabine comb ...... F-κB mediated uPAR activation.
@en
P2093
P2860
P1433
P1476
AduPARE1A and gemcitabine comb ...... NF-κB mediated uPAR activation
@en
P2093
Ana Mato-Berciano
Anabel José
Cristina Fillat
Luciano Sobrevals
Maria Victoria Maliandi
P2860
P2888
P356
10.1186/S12943-015-0413-2
P50
P577
2015-07-31T00:00:00Z
P5875
P6179
1032885021